Symptomatic cases drop 94% with Pfizer vaccine, study finds

Symptomatic cases of COVID-19 have dropped 94% after two doses of the Pfizer vaccine, according to a new study.

Israel’s largest healthcare provider, Clalit, looked at data from more than 600,000 people in what is believed to be the country’s largest study to date.

The study also found that people were 92% less likely to develop serious illness from the virus with the inoculations.

“This unequivocally shows that Pfizer’s coronavirus vaccine is extremely effective in the real world one week after the second dose, just as it was found in the clinical study,” said Ran Balicer, chief innovation officer by Clalit.

The shot becomes even more effective two or more weeks after the second dose, Balicer said.

Researchers at the Weizmann Institute of Sciences also reported on Sunday that there was for the first time a significant drop in hospitalizations and serious illness among Israelis aged 55 and older.

The first age group to be vaccinated in the country was those aged 60 and over.

With pole wires